Abstract: A respiration promoting apparatus and a method for promoting respiration for coordinately stimulating two Phrenic nerves of a patient for activating a diaphragm of the patient comprising a first coil unit (91), a second coil unit (92) and a bracket structure (93). The first coil unit (91) has a first forward face (911) configured to be positioned at the patient to stimulate a first Phrenic nerve of the two Phrenic nerves (62) of the patient. The second coil unit (92) has a second forward face (921) configured to be positioned at the patient to stimulate a second Phrenic nerve. The bracket structure (93) is coupled to the first coil unit (91) and the second coil unit (92) and is adjustable such that positions and orientations of the first coil unit (91) and of the second coil unit (92) are adapted. The bracket structure (93) has a third forward face (918, 928, 932) configured to be positioned at the patient.

Abstract: A stimulation device and a method to coordinately stimulate two separate nerves in a human or animal body for activating a target tissue in the human or animal body comprises a first coil unit (91) configured to be positioned at the human or animal body to stimulate a first nerve of the two separate nerves, a second coil unit (92) configured to be positioned at the human or animal body to stimulate a second nerve of the two separate nerves; and a bracket structure (93) coupled to the first coil unit (91) and the second coil unit (92). The bracket structure (93) is adjustable such that positions and orientations of the first coil unit (91) and of the second coil unit (92) relative to each other are adaptable to a target configuration in which the first coil unit (91) and the second coil unit (92) are distinctly positioned at the human or animal body such that the first nerve can be stimulated by the first coil unit (91) and the second nerve can be stimulated by the second coil unit (93).

Abstract: A stimulation device is disclosed to coordinately stimulate a first nerve and a second nerve in a human or animal body for activating a target tissue in the human or animal body. The stimulation device includes a first coil unit configured to be positioned at the body to stimulate the first nerve, a second coil unit configured to be positioned at the body to stimulate the second nerve, and a connector connected with the first and second coil units. The connector, and the first and second coil units are electrically connected in series. The first and the second coil unit are individually positionable at the human or animal body. In other words, the coil units can be independently moveable. Thereby the positions and orientations of the first coil unit and the second coil unit can be freely adapted according to the need.

Abstract: The present invention discloses a stimulation device to securely stimulate a first and a second nerve in a human or animal body for activating a target tissue in the human or animal body, comprising: a first coil unit configured to be positioned at the human or animal body to stimulate the first nerve; a second coil unit configured to be positioned at the human or animal body to stimulate the second nerve; wherein the first and second coil units are arranged such that a sum of the electro-magnetic field generated by the first and second coil units respectively is about zero, e.g. arranged axial or substantially axial, and comprise windings wound in opposite directions; and a control unit configured to initiate the stimulation, in accordance with a predefined security policy including conditions to activate or prevent the stimulation.

Abstract: The invention discloses a stimulation device to stimulate a first and a second Phrenic nerve in a human or animal body for activating a target tissue or diaphragm in the human or animal body, wherein the stimulation device comprises: a first coil unit configured to be positioned at the human or animal body to stimulate the first Phrenic nerve, and a second coil unit configured to be positioned at the human or animal body to stimulate the second Phrenic nerve. Each of the at least two coil windings of each of the first and second coil units is wound with a variable radius into a spiral, and has at least one essentially straight-lined side. The at least two coil windings of each of the first and second coil are stacked on top of each other.

Abstract: A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.

Abstract: A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.

Abstract: A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.

Abstract: A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.

Abstract: A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.

Abstract: A Direct Sodium Removal method, apparatus and solution for treating patients in heart failure, and having a glomerular filtration rate greater than 15 mL/min/1.73 m2, or residual kidney function corresponding to normal to CKD Stage 4, is provided in which a no or low sodium DSR infusate is administered to the peritoneal cavity for a predetermined dwell period and then removed, thereby removing sodium from the body. The resulting elimination of fluid from the patient by i) functioning of the kidneys through urination and ii) direct removal of osmotic ultrafiltrate from the peritoneal cavity, restores serum sodium concentrations to healthy levels and thereby reduces fluid overload in the patient.

Abstract: The deflection apparatus (1) for the deflection of electromagnetic radiation, in particular of a laser beam, includes a drive apparatus (2) and includes a beam deflection apparatus (4), in particular a mirror (4), which is arranged with the drive device (2) such that the drive apparatus (2) determines the alignment of the beam deflection apparatus (4), and includes a friction apparatus (5) which is arranged and made such that it brings about static friction or sliding friction onto the movably journaled beam deflection apparatus (4), with the drive apparatus (2) being made such that it can generate a drive force which overcomes the static friction, and includes a control apparatus (10) for the control of the drive apparatus (2). (FIG.

Abstract: A method of controlling a machine connected to a display comprising an absolute pointing method providing a wearable apparatus (1) including an image sensor (61) worn on an operator's head (58) or ear and adjustable so that the pointing direction (57) of the image sensor (61) is congruent with the operator's focus point on said display (45) when relative head-eye movements are small. A processor (33) analyzes images (103) of the display environment taken by the image sensor (61) and determines the pointing direction (57) of the image sensor with respect to the display outline (50). The wearable apparatus (1) further includes a microphone (8) for initiating actions on said machine by audio commands. Other means for initiating actions includes detecting certain head movements and a special keyboard driver. The method further comprises means for feedback from the wearable apparatus (1) to the machine.

Abstract: A respiratory analyzer comprises a flow module, having a flow tube through which the flow rate of gases is determined using a flow rate meter, and a computation module, in communication with the flow module, operable to determine a flow rate of respired gases. The computation module may also be operable to determine a metabolic rate of the subject.

Abstract: A respiratory analyzer comprises a flow module, having a flow tube through which the flow rate of gases is determined using a flow rate meter, and a computation module, in communication with the flow module, operable to determine a flow rate of respired gases. The computation module may also be operable to determine a metabolic rate of the subject.